Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >
Altered balance of epidermis-related chemokines in epidermolysis bullosa
This item is licensed under:Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Title: | Altered balance of epidermis-related chemokines in epidermolysis bullosa |
Authors: | Ujiie, Inkin Browse this author | Fujita, Yasuyuki Browse this author | Nakayama, Chihiro Browse this author | Matsumura, Wakana Browse this author | Suzuki, Shotaro Browse this author | Shinkuma, Satoru Browse this author →KAKEN DB | Nomura, Toshifumi Browse this author | Abe, Riichiro Browse this author →KAKEN DB | Shimizu, Hiroshi Browse this author →KAKEN DB |
Keywords: | Epidermolysis bullosa | Chemokine | CCL27 | HMGB1 | SDF-1 |
Issue Date: | Apr-2017 |
Publisher: | Elsevier |
Journal Title: | Journal of dermatological science |
Volume: | 86 |
Issue: | 1 |
Start Page: | 37 |
End Page: | 45 |
Publisher DOI: | 10.1016/j.jdermsci.2016.12.021 |
PMID: | 28094098 |
Abstract: | Background: Epidennolysis bullosa (EB) is a congenital, refractory skin disease and there are no fundamental treatments. Recently, allogenic cell therapies are beginning to be applied as potential treatments, that are based on the concept that the allogenic cells can migrate into the skin and reconstitute the skin components. Although the mechanisms of cell migration into skin are not fully understood, chemokines are regarded as key factors in recruiting bone marrow-derived cells. Objectives: Our study aims to elucidate the expression of chemokines in the EB patients. Methods: We determined the expression of wound-healing related chemokines in the sera, keratinocytes, and skin tissues of EB patients and compared them to those of healthy volunteers by enzyme-linked immunosorbent assays, quantitative reverse transcription PCR, and immunofluorescence staining. Results: The serum levels of CXCL12 and HMGB1 were found to be significantly elevated in the EB patients. Conversely, the serum levels of CCL21 were found to be lower in the EB patients than in healthy controls. In addition, the serum levels of CXCL12 tended to increase and the serum levels of CCL27 tended to decrease with an increase in the affected body surface areas. To detect the origin of the circulating chemokines, we performed immunofluorescence staining. CCL21, CCL27, HMGB1 and CXCL12 were stained more broadly in the EB patient tissues than those in the control tissues. Conclusions: These results suggest that fluctuations in chemokine levels may contribute in a coordinated way to the wound-healing process and lend clues toward efficient cell therapies for EB. |
Rights: | © 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
Type: | article (author version) |
URI: | http://hdl.handle.net/2115/68661 |
Appears in Collections: | 医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 氏家 韻欣
|